Cargando…
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
BACKGROUND & AIMS: β-catenin is a well-known effector of the Wnt pathway, and a key player in cadherin-mediated cell adhesion. Oncogenic mutations of β-catenin are very frequent in paediatric liver primary tumours. Those mutations are mostly heterozygous, which allows the co-expression of wild-t...
Autores principales: | Gest, Caroline, Sena, Sandra, Dif, Lydia, Neaud, Véronique, Loesch, Robin, Dugot-Senant, Nathalie, Paysan, Lisa, Piquet, Léo, Robbe, Terezinha, Allain, Nathalie, Dembele, Doulaye, Guettier, Catherine, Bioulac-Sage, Paulette, Rullier, Anne, Le Bail, Brigitte, Grosset, Christophe F., Saltel, Frédéric, Lagrée, Valérie, Colnot, Sabine, Moreau, Violaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159820/ https://www.ncbi.nlm.nih.gov/pubmed/37153687 http://dx.doi.org/10.1016/j.jhepr.2023.100691 |
Ejemplares similares
-
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling
por: Indersie, Emilie, et al.
Publicado: (2017) -
Identification of an inhibitory domain in GTPase-activating protein p190RhoGAP responsible for masking its functional GAP domain
por: Héraud, Capucine, et al.
Publicado: (2022) -
Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo
por: Indersie, Emilie, et al.
Publicado: (2018) -
Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia
por: Vial, Guillaume, et al.
Publicado: (2019) -
New tumor suppressor microRNAs target glypican-3 in human liver cancer
por: Cartier, Flora, et al.
Publicado: (2017)